Related Experiment Videos
[Isosorbide dinitrate and bupranolol in the therapy of coronary heart disease (author's transl)]
Insights
A combination of long-acting nitrite and beta-receptor blockers effectively reduced hemodynamic changes in coronary heart disease patients during physical and mental stress. This treatment shows promise for managing stress responses in coronary heart disease.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Coronary heart disease (CHD) involves detrimental hemodynamic changes during stress.
- Current management strategies aim to mitigate these responses.
Purpose of the Study:
- To evaluate the efficacy of a combined long-acting nitrite and beta-receptor blocker therapy.
- To assess the impact of this combination on hemodynamic responses to physical and mental stress in CHD patients.
Main Methods:
- A study involving sixteen patients with coronary heart disease and three healthy volunteers.
- Administration of a combination of a long-acting nitrite and a beta-receptor blocking agent.
- Monitoring hemodynamic changes following physical and mental stress induction.
Main Results:
- The drug combination demonstrated effectiveness in reducing hemodynamic alterations.
- Significant diminishment of adverse hemodynamic changes was observed after both physical and mental stressors.
- The treatment was well-tolerated by the study participants.
Conclusions:
- Combined therapy with long-acting nitrite and beta-receptor blockers is effective in managing stress-induced hemodynamic changes in coronary heart disease.
- Findings support the potential of this therapeutic approach in mitigating CHD pathogenetic mechanisms related to stress.
Abstract:
Sixteen patients with coronary heart disease (CHD) and three healthy volunteers were treated with a combination of a long-acting nitrite and a beta-receptor blocking agent. The drug proved effective in diminishing haemodynamic changes after physical and mental stress, respectively. The implications of these findings are discussed in the light of recent knowledge on CHD pathogenetic mechanisms.